Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pulsed moxifloxacin for prevention of acute exacerbations in chronic bronchitis
2004-000404-40Phase 3Completed
- Sponsor
- Bayer
- Start
- Aug 2004
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Covalent Small Molecules → Small Molecules, Nucleic Acid-Directed Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in chronic bronchitis (CB) comparing Moxifloxacin with Placebo (2 arms). Primary endpoint: Frequency of acute exacerbations of chronic bronchitis. Started Aug 2004; status: completed.
02
Drugs
moxifloxacin
03
Conditions
chronic bronchitis (CB)
Beyond the preview
Go deeper on 2004-000404-40.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2004-000404-40.